| Consensus paper: management of degenerative cerebellar disorders W Ilg, AJ Bastian, S Boesch, RG Burciu, P Celnik, J Claaßen, K Feil, ... The Cerebellum 13, 248-268, 2014 | 222 | 2014 |
| Features of human CD3+ CD20+ T cells E Schuh, K Berer, M Mulazzani, K Feil, I Meinl, H Lahm, M Krane, ... The Journal of Immunology 197 (4), 1111-1117, 2016 | 192 | 2016 |
| A multicenter observational study on the role of comorbidities in the recurrent episodes of benign paroxysmal positional vertigo A De Stefano, F Dispenza, H Suarez, N Perez-Fernandez, ... Auris nasus larynx 41 (1), 31-36, 2014 | 170 | 2014 |
| Effects of acetyl-dl-leucine in patients with cerebellar ataxia: a case series M Strupp, J Teufel, M Habs, R Feuerecker, C Muth, ... Journal of neurology 260, 2556-2561, 2013 | 125 | 2013 |
| Aminopyridines for the treatment of neurologic disorders M Strupp, J Teufel, A Zwergal, R Schniepp, K Khodakhah, K Feil Neurology: Clinical Practice 7 (1), 65-76, 2017 | 95 | 2017 |
| Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial ST Engelter, C Traenka, H Gensicke, SA Schaedelin, AR Luft, ... The Lancet Neurology 20 (5), 341-350, 2021 | 93 | 2021 |
| Cerebellar ataxias: an update M Manto, J Gandini, K Feil, M Strupp Current opinion in neurology 33 (1), 150-160, 2020 | 83 | 2020 |
| Bilateral vestibulopathy M Strupp, K Feil, M Dieterich, T Brandt Handbook of clinical neurology 137, 235-240, 2016 | 81 | 2016 |
| Effect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial K Feil, J Claaßen, S Bardins, J Teufel, S Krafczyk, E Schneider, ... Neurology 81 (13), 1152-1158, 2013 | 64 | 2013 |
| What is behind cerebellar vertigo and dizziness? K Feil, R Strobl, A Schindler, S Krafczyk, N Goldschagg, C Frenzel, ... The Cerebellum 18, 320-332, 2019 | 61 | 2019 |
| Acetyl-DL-leucine improves gait variability in patients with cerebellar ataxia—a case series R Schniepp, M Strupp, M Wuehr, K Jahn, M Dieterich, T Brandt, K Feil Cerebellum & ataxias 3, 1-4, 2016 | 59 | 2016 |
| Pathological ponto-cerebello-thalamo-cortical activations in primary orthostatic tremor during lying and stance F Schöberl, K Feil, G Xiong, P Bartenstein, C la Fougere, K Jahn, T Brandt, ... Brain 140 (1), 83-97, 2017 | 54 | 2017 |
| Stroke etiology modifies the effect of endovascular treatment in acute stroke S Tiedt, M Herzberg, C Küpper, K Feil, L Kellert, F Dorn, T Liebig, ... Stroke 51 (3), 1014-1016, 2020 | 50 | 2020 |
| Long-term course of orthostatic tremor in serial posturographic measurement K Feil, N Böttcher, F Guri, S Krafczyk, F Schöberl, A Zwergal, M Strupp Parkinsonism & related disorders 21 (8), 905-910, 2015 | 50 | 2015 |
| Dalfampridine in patients with downbeat nystagmus—an observational study J Claassen, K Feil, S Bardins, J Teufel, R Spiegel, R Kalla, E Schneider, ... Journal of neurology 260, 1992-1996, 2013 | 48 | 2013 |
| Intravenous thrombolysis in patients with ischemic stroke and recent ingestion of direct oral anticoagulants TR Meinel, D Wilson, H Gensicke, JF Scheitz, P Ringleb, I Goganau, ... JAMA neurology 80 (3), 233-243, 2023 | 45 | 2023 |
| Pharmacotherapy of vestibular and cerebellar disorders and downbeat nystagmus: Translational and back‐translational research M Strupp, A Zwergal, K Feil, T Bremova, T Brandt Annals of the new York Academy of Sciences 1343 (1), 27-36, 2015 | 45 | 2015 |
| Tandem lesions in anterior circulation stroke: analysis of the German Stroke Registry–Endovascular Treatment K Feil, M Herzberg, F Dorn, S Tiedt, C Küpper, DC Thunstedt, ... Stroke 52 (4), 1265-1275, 2021 | 44 | 2021 |
| The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia G Uzun, K Althaus, A Singh, P Möller, U Ziemann, A Mengel, ... Blood, The Journal of the American Society of Hematology 138 (11), 992-996, 2021 | 43 | 2021 |
| Clinical and imaging parameters associated with hyperacute infarction growth in large vessel occlusion stroke D Puhr-Westerheide, S Tiedt, LT Rotkopf, M Herzberg, P Reidler, ... Stroke 50 (10), 2799-2804, 2019 | 39 | 2019 |
